Back to Search Start Over

Perceptions, Experiences, and Patterns of Cannabis Use in Individuals with Mood and Anxiety Disorders in the Context of Cannabis Legalization and Medical Cannabis Program in Canada – A Qualitative Study.

Authors :
Das, Ankita
Hendershot, Christian S.
Husain, M.Ishrat
Knyahnytska, Yuliya
Elsaid, Sonja
Le Foll, Bernard
Kloiber, Stefan
Source :
Pharmacopsychiatry. May2024, Vol. 57 Issue 3, p141-151. 11p.
Publication Year :
2024

Abstract

Introduction Perceptions of cannabis as a potential medical treatment for mood and anxiety disorders have been increasing in the context of legalizations, availability, and medical cannabis programs, though current evidence predominately indicates risks and negative effects of cannabis use (CU) on mental health outcomes. This study aims to understand motivations, perceptions, effects, and patterns of CU in individuals with mood and anxiety disorders. Methods Thirty-six adult patients diagnosed with mood or anxiety disorders, obsessive-compulsive disorder, or posttraumatic stress disorder who were currently using cannabis completed an in-depth qualitative interview on individual motivations, perceptions, experiences, effects, and patterns of their CU. The thematic analysis focused on phases of CU and sources of cannabis products and information. Results Reported motivations for initiation of CU included curiosity, peer pressure, and dissatisfaction with conventional treatments. Factors such as psychotropic effects and coping with mental health symptoms and insomnia contributed to the continuation of CU. More negative effects, including cognitive dysfunction, worsening of mood, and anxiety symptoms, were acknowledged with ongoing CU. Concerning findings included common initiation of CU before age 18, combined medical and recreational CU, rare consultation of medical professionals on CU, and potential effects and harms. Discussion Findings indicate individual complexity of motivations, perceptions, and patterns of CU in the study population. The reported potential beneficial effects of specific cannabis products should be further investigated. Findings emphasize patient-provider dialogue on both CU and conventional treatments. Information from this study can contribute to and inform the development of education, prevention, and intervention strategies. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
01763679
Volume :
57
Issue :
3
Database :
Academic Search Index
Journal :
Pharmacopsychiatry
Publication Type :
Academic Journal
Accession number :
177082854
Full Text :
https://doi.org/10.1055/a-2264-1047